Request Call Back

Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Advair Side Effects Lawsuits | Side Effects: Bronchitis, Cough, Vomiting, Diarrhea, Difficulty Speaking, Fungal Infection, Headaches

Advair Side Effects Linked To Asthma-Related Death Lawsuits

Advair | Lawyer, Lawsuit | Side Effects: Bronchitis, Cough, Vomiting, Diarrhea, Difficulty Speaking, Fungal Infection, Headaches

Advair Side Effects

Advair Diskus

The Advair Diskus inhaler contains a combination of fluticasone and salmeterol and is used to treat asthma. Fluticasone and salmeterol shrink the swelling in the airways and relax and open air passages in the lungs. Advair was approved in 2000, by the FDA and is made by GlaxoSmithKline.

The FDA, on November 15, 2005 issued a public health advisory about potentially fatal side effects from two GlaxoSmithKline asthma drugs. The agency is asking the maker of the drugs, Advair Diskus and Serevent Diskus, to add warnings to their labels that these medications may increase the chance of severe asthma episodes, and death when those episodes occur.

Advair Increase The Chance Of Severe Asthma

Advair is GlaxoSmithKline's biggest product, with $4 billion in sales during the first nine months of 2005. Serevent's sales were $450 million. Advair is a long-acting beta 2-adrenergic agonist, or LABA, which provides asthma relief by relaxing muscles around the airways to the lungs. Although they can reduce the number of asthma episodes, the FDA says they "may increase the chances of a severe asthma episode when they do occur.

In one study, the agency says, "an increased number of people taking a LABA in addition to their usual asthma care died from their asthma compared to people taking a placebo in addition to their usual asthma care, although the number of asthma deaths in the study was small.

In August 2003, the FDA announced the addition of new safety information and warnings to the labeling for drug products that contain salmeterol. The new labeling includes a boxed warning about a small, but significant, increased risk of life-threatening asthma episodes or asthma-related deaths observed in patients taking salmeterol in a recently completed large U.S. safety study Advair Label.

Update On May 16, 2006, The FDA announced that the product label for Advair has been updated with a warning that the drug might well increase the chance of severe asthma attacks that can result in death.

Side effects of Advair may consist of the following: bronchitis, cough, vomiting, diarrhea, difficulty speaking, fungal infection of the mouth, headaches, stomach pain, hoarseness, muscle and bone pain, nausea, sore throat and sinus pain.

Need Legal Help Regarding Advair Effects?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).



AdvairRSS Feed

Warnings for Long-Acting Asthma Drugs Take Effect

Jun 3, 2010 | Parker Waichman LLP
New warnings for the inhaled asthma drugs Advair, Serevent, Foradil and Symbicort have been finalized by the U.S. Food & Drug Administration (FDA). The new warnings were requested by the agency in February, but according to Reuters, the FDA had to exercise new powers to order the changes on Advair and Serevent, both marketed by GlaxoSmithKline, as well as AstraZeneca’s Symbicort. All of these drugs are known as long-acting beta agonists (LABAs). LABAs prevent the release of...

FDA Seeks to Limit Use of Serevent, Advair, Symbicort and Foradil

Feb 19, 2010 | Parker Waichman LLP
U.S. regulators want to limit the use of Serevent, Advair, Symbicort and Foradil.  The four drugs, part of a class of asthma medications known as long-acting beta agonists (LABAs), are being subjected to new restrictions, the U.S. Food & Drug Administration (FDA) has announced. These drugs are approved to treat both people with asthma or with chronic obstructive pulmonary disease (COPD). The new recommendations announced by the FDA only apply to the use of LABAs in the treatment of...

Advair, Symbicort Up Pneumonia Risks for COPD Sufferers

Feb 11, 2009 | Parker Waichman LLP
Advair, Symbicort and other inhaled corticosteroids may increase the risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD) by as much as 70%, according to a news study.   The study, conducted by researchers at Wake Forest University Baptist Medical Center, was published in the Feb. 9 issue of the Archives of Internal Medicine.Advair, and Symbicort are known as long-acting beta-agonists (LABA), a class of drugs used to treat asthma.  Both Advair and...

FDA Panel Wants Restrictions on Two Asthma Drugs

Dec 12, 2008 | Parker Waichman LLP
A U.S. Food and Drug Administration (FDA) panel has called for restrictions on two asthma treatments:  Serevent and Foradil.  Both belong to a class  of drugs known as long-acting beta-agonists.  Both contain a drug that relaxes muscles around airways, said WHEC TV, but may also mask symptoms that can prompt deadly asthma attacks.  Although the expert 27-member panel found Serevent and Foradil drugs present greater risks than benefits and should not be used in the...

FDA Considers Heart Risks of Serevent, Foradil, Advair and Symbicort

Dec 11, 2008 | Parker Waichman LLP
liable LABAs are used by millions of patients, many of whom are children, noted Reuters.  Advair and Symbicort use a LABA with an inhaled steroid; Serevent and Foradil (marketed in the U.S. by Schering-Plough Corp.) only contain LABAs, said Reuters.Reuters explained that asthma, a chronic disease with symptoms that include restricted breathing and wheezing, can be fatal when untreated or uncontrolled.  About 20 million Americans suffer from asthma, according to the National...

More Advair News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo